Presentation is loading. Please wait.

Presentation is loading. Please wait.

Vaccine in National Immunization Programme Update

Similar presentations


Presentation on theme: "Vaccine in National Immunization Programme Update"— Presentation transcript:

1 Vaccine in National Immunization Programme Update
April 2016

2 Countries with Hib vaccine in the national immunization programme
Introduced to date Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Côte d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, The former Yugoslav Republic of Macedonia, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Not Available, Not Introduced/No Plans China, Thailand Partial introductions are: Belarus, India and Russian Federation Introduced* to date (192 countries or 99%) Not Available, Not Introduced/No Plans * Includes partial introduction (2 countries or 1%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

3 Countries using IPV vaccine to date
This information is available from the IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening: activated_polio_vaccine/en/ (click on the hyperlink to access the website – on its right hand column a slide set presentation is downloadable)

4 Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2016 Introduced to date Afghanistan, Albania, Andorra, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Benin, Bolivia, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Central African Republic, Chile, Colombia, Congo, Costa Rica, Côte d'Ivoire, Cyprus, Democratic Republic of the Congo, Denmark, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Ethiopia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Guatemala, Guinea-Bissau, Guyana, Honduras, Hungary, Iceland, Ireland, Israel, Italy, Japan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Morocco, Mozambique, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Portugal, Qatar, Republic of Korea, Republic of Moldova, Russian Federation, Rwanda, Sao Tome and Principe, Saudi Arabia, Senegal, Sierra Leone, Singapore, Slovakia, Solomon Islands, South Africa, Sudan, Swaziland, Sweden, Switzerland, Togo, Trinidad and Tobago, Turkey, Uganda, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Venezuela, Yemen, Zambia, Zimbabwe Partial Introductions in the Philippines, Russian Federation, Kazakhstan and Nigeria Planned introductions in 2016 Indonesia, Iraq, Mongolia, Myanmar, Spain, Suriname Not Available, Not Introduced/No Plans Algeria, Antigua and Barbuda, Belarus, Belize, Bhutan, Bosnia and Herzegovina, Brunei Darussalam, Cabo Verde, Chad, China, Comoros, Cook Islands, Croatia, Cuba, Czech Republic, Democratic People's Republic of Korea, Dominica, Egypt, Equatorial Guinea, Estonia, Gabon, Grenada, Guinea, Haiti, India, Iran (Islamic Republic of), Jamaica, Jordan, Malaysia, Maldives, Malta, Montenegro, Nauru, Poland, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Serbia, Seychelles, Slovenia, Somalia, South Sudan, Sri Lanka, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Tunisia, Turkmenistan, Tuvalu, Ukraine, Vanuatu, Viet Nam Introduced* to date (130 countries or 67%) Planned introductions in 2016 (6 countries or 3.1%) Not Available, Not Introduced/No Plans * Includes partial introduction (58 countries or 29.9%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

5 Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2016 Introduced to date Angola, Argentina, Armenia, Australia, Austria, Bahrain, Belgium, Bolivia, Botswana, Brazil, Burkina Faso, Burundi, Cameroon, Canada, Colombia, Congo, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Estonia, Ethiopia, Fiji, Finland, Gambia, Georgia, Germany, Ghana, Greece, Guatemala, Guinea-Bissau, Guyana, Haiti, Honduras, India, Iraq, Israel, Jordan, Kenya, Kiribati, Latvia, Libya, Luxembourg, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Morocco, Mozambique, Namibia, New Zealand, Nicaragua, Niger, Norway, Palau, Panama, Paraguay, Peru, Philippines, Qatar, Republic of Moldova, Rwanda, Saudi Arabia, Senegal, Sierra Leone, South Africa, Sudan, Swaziland, Sweden, Tajikistan, Thailand, Togo, United Kingdom, United Republic of Tanzania, United States of America, Uzbekistan, Venezuela, Yemen, Zambia, Zimbabwe Partial introduction in Canada, India, Mali, the Philippines, Sweden, Thailand Planned introductions in 2016 Albania, Côte d'Ivoire, Liberia, Sao Tome and Principe, Seychelles, Uganda Not Available, Not Introduced/No Plans Afghanistan, Algeria, Andorra, Antigua and Barbuda, Azerbaijan, Bahamas, Bangladesh, Barbados, Belarus, Belize, Benin, Bhutan, Bosnia and Herzegovina, Brunei Darussalam, Bulgaria, Cabo Verde, Cambodia, Central African Republic, Chad, Chile, China, Comoros, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Democratic Republic of the Congo, Denmark, Dominica, Egypt, Equatorial Guinea, France, Gabon, Grenada, Guinea, Hungary, Iceland, Indonesia, Iran (Islamic Republic of), Ireland, Italy, Jamaica, Japan, Kazakhstan, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Lebanon, Lesotho, Lithuania, Malaysia, Maldives, Malta, Monaco, Mongolia, Montenegro, Myanmar, Nauru, Nepal, Netherlands, Nigeria, Niue, Oman, Pakistan, Papua New Guinea, Poland, Portugal, Republic of Korea, Romania, Russian Federation, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Serbia, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Sudan, Spain, Sri Lanka, Suriname, Switzerland, Syrian Arab Republic, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, Uruguay, Vanuatu, Viet Nam Introduced* to date (85 countries or 43.8%) Planned introductions in 2016 (6 countries or 3.1%) Not Available, Not Introduced/No Plans * Includes partial introduction (103 countries or 53.1%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

6 Countries with HPV vaccine in the national immunization programme
Introduced to date Andorra, Argentina, Australia, Austria, Bahamas, Barbados, Belgium, Bhutan, Botswana, Brazil, Brunei Darussalam, Canada, Chile, Colombia, Cook Islands, Czech Republic, Denmark, Ecuador, Fiji, Finland, France, Germany, Greece, Guyana, Hungary, Iceland, Ireland, Israel, Italy, Japan, Kazakhstan, Latvia, Lesotho, Libya, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Micronesia (Federated States of ), Monaco, Netherlands, New Zealand, Norway, Palau, Panama, Paraguay, Peru, Portugal, Russian Federation, Rwanda, San Marino, Seychelles, Singapore, Slovenia, South Africa, Spain, Suriname, Sweden, Switzerland, The former Yugoslav Republic of Macedonia, Trinidad and Tobago, Uganda, United Kingdom, United States of America, Uruguay Partial introduction are in Guyana, Kazakhstan and Russian Federation Not Available, Not Introduced/No Plans Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Armenia, Azerbaijan, Bahrain, Bangladesh, Belarus, Belize, Benin, Bolivia, Bosnia and Herzegovina, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic, Chad, China, Comoros, Congo, Costa Rica, Côte d'Ivoire, Croatia, Cuba, Cyprus, Democratic People's Republic of Korea, Democratic Republic of the Congo, Djibouti, Dominica, Dominican Republic, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Gabon, Gambia, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Haiti, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Jamaica, Jordan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Lebanon, Liberia, Lithuania, Madagascar, Malawi, Maldives, Mali, Mauritania, Mauritius, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Papua New Guinea, Philippines, Poland, Qatar, Republic of Korea, Republic of Moldova, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Sierra Leone, Slovakia, Solomon Islands, Somalia, South Sudan, Sri Lanka, Sudan, Swaziland, Syrian Arab Republic, Tajikistan, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Republic of Tanzania, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Introduced* to date (66 countries or 34%) Not Available, Not Introduced/No Plans (128 countries or 66%) * Includes partial introduction Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

7 Countries using Measles Second Dose vaccine to date; and planned introductions in 2016
Introduced to date Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Bhutan, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Canada, Chile, China, Colombia, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Denmark, Djibouti, Dominica, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guyana, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Latvia, Lebanon, Lesotho, Libya, Lithuania, Luxembourg, Malawi, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Nauru, Nepal, Netherlands, New Zealand, Niger, Niue, Norway, Oman, Pakistan, Palau, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Planned introductions in 2016 Namibia, Papua New Guinea, Uganda Not Available, Not Introduced/No Plans Benin, Bolivia, Cameroon, Central African Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Dominican Republic, Equatorial Guinea, Ethiopia, Gabon, Guatemala, Guinea, Guinea-Bissau, Haiti, Honduras, Lao People's Democratic Republic, Liberia, Madagascar, Mali, Mauritania, Nicaragua, Nigeria, Solomon Islands, Somalia, South Sudan, Timor-Leste, Togo, Vanuatu Introduced to date (160 countries or 82.5%) Planned introductions in 2016 (3 countries or 1.5%) Not Available, Not Introduced/No Plans (31 countries or 16%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

8 Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2016 Introduced to date Albania, Andorra, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Bhutan, Bolivia, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Cabo Verde, Cambodia, Cameroon, Canada, Chile, China, Colombia, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Fiji, Finland, France, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guyana, Haiti, Honduras, Hungary, Iceland, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Myanmar, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niue, Norway, Oman, Palau, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Saudi Arabia, Senegal, Serbia, Seychelles, Singapore, Slovakia, Slovenia, Solomon Islands, Spain, Sri Lanka, Suriname, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zimbabwe Planned introductions in 2016 Botswana, Burundi, Gambia, India, Kenya, Lesotho, Namibia, Papua New Guinea, Sao Tome and Principe, Swaziland, Zambia Not Available, Not Introduced/No Plans Afghanistan, Algeria, Angola, Benin, Central African Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic People's Republic of Korea, Democratic Republic of the Congo, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Guinea, Guinea-Bissau, Indonesia, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Niger, Nigeria, Pakistan, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Togo, Uganda Introduced to date (148 countries or 76.3%) Planned introductions in 2016 (11 countries or 5.7%) Not Available, Not Introduced/No Plans (35 countries or 18%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

9 Countries with Hepatitis B Birth dose (HepB-BD) vaccine in the national immunization programme
HepB-BD introduced to date: Afghanistan Albania Algeria Andorra Angola Argentina Armenia Australia Azerbaijan Bahrain Belarus Bhutan Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Cabo Verde Cambodia China Colombia Cook Islands Costa Rica Croatia Cuba Democratic People’s Republic of Korea (the) Djibouti Dominican Republic (the) Ecuador El Salvador Estonia Fiji Gambia (the) Georgia Guatemala Honduras India Indonesia Iran (Islamic Republic of) Iraq Israel Kazakhstan Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic (the) Lebanon Libya Lithuania Malaysia Maldives Marshall Islands (the) Mauritania Mexico Micronesia (Federated States of) Mongolia Morocco Namibia Nauru Nigeria Niue Oman Palau Panama Papua New Guinea Peru Philippines (the) Poland Portugal Qatar Republic of Korea (the) Republic of Moldova (the) Romania Russian Federation (the) Samoa Saudi Arabia Senegal Serbia Singapore Solomon Islands Spain Suriname Syrian Arab Republic (the) Tajikistan Thailand The former Yugoslav Republic of Macedonia Tonga Tunisia Turkey Turkmenistan Tuvalu Ukraine United Arab Emirates (the) United States of America (the) Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam HepB-BD only for infants born to HBsAG-positive mothers Belgium Czech Republic (the) Denmark France Greece Italy Latvia Luxembourg Monaco Netherlands (the) New Zealand Norway Paraguay Saint Lucia Saint Vincent and the Grenadines Sao Tome and Principe Slovakia Slovenia Sweden Switzerland United Kingdom of Great Britain and Northern Ireland (the) HepB in schedule but no HepB-BD Antigua and Barbuda Austria Bahamas (the) Bangladesh Barbados Belize Benin Bolivia (Plurinational State of) Burkina Faso Burundi Cameroon Canada Central African Republic (the) Chad Chile Comoros (the) Congo (the) Côte d'Ivoire Cyprus Democratic Republic of the Congo (the) Dominica Egypt Equatorial Guinea Eritrea Ethiopia Gabon Germany Ghana Grenada Guinea Guinea-Bissau Guyana Haiti Ireland Jamaica Jordan Kenya Lesotho Liberia Madagascar Malawi Mali Malta Mauritius Montenegro Mozambique Myanmar Nepal Nicaragua Niger (the) Pakistan Rwanda Saint Kitts and Nevis San Marino Seychelles Sierra Leone Somalia South Africa South Sudan Sri Lanka Sudan (the) Swaziland Timor-Leste Togo Trinidad and Tobago Uganda United Republic of Tanzania (the) Uruguay Yemen Zambia Zimbabwe HepB given only for risk groups or adolescents Finland Hungary Iceland Japan HepB-BD introduced to date (98 countries or 51%) HepB-BD only for infants born to HBsAG-positive mothers (21 countries or 11%) (71 countries or 37%) HepB in schedule but no HepB-BD Data source: WHO/IVB Databse as at 12 April 2016 and ECDC published data at 194 WHO Member States Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 12 April 2016 HepB given only for risk groups or adolescents (4 countries or 2%) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Not applicable

10 Countries with Influenza vaccine in the national immunization programme
Introduced to date Algeria Andorra Antigua and Barbuda Argentina Australia Austria Bahamas (the) Bahrain Barbados Belarus Belgium Belize Bolivia (Plurinational State of) Brazil Brunei Darussalam Bulgaria Canada Chile China Colombia Cook Islands Costa Rica Cuba Cyprus Czech Republic (the) Denmark Dominica Dominican Republic (the) Ecuador Egypt El Salvador Estonia Finland France Georgia Germany Grenada Guatemala Honduras Hungary Iceland Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kuwait Lao People’s Democratic Republic (the) Latvia Libya Luxembourg Malaysia Malta Marshall Islands (the) Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Montenegro Morocco Nauru Nepal Netherlands (the) New Zealand Nicaragua Niue Norway Oman Palau Panama Paraguay Peru Philippines (the) Portugal Qatar Republic of Korea (the) Republic of Moldova (the) Romania Russian Federation (the) Saint Lucia Saudi Arabia Serbia Slovakia Slovenia South Africa Spain Suriname Switzerland Thailand Trinidad and Tobago Tunisia Turkey Turkmenistan United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Venezuela (Bolivarian Republic of) Partial introduction: Maldives and Sweeden Introduced to date (103 countries or 53%) Introduced in parts of the country (2 countries or 1%) Not Available, Not Introduced/No Plans (89 countries or 46%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

11 Countries and Territories using Yellow fever* vaccine to date
Introduced to date Angola, Benin, Bolivia (Plurinational State of), Burkina Faso, Cameroon, Central African Republic (the), Chad, Colombia, Congo (the), Côte d'Ivoire, Democratic Republic of the Congo (the), Ecuador, French Guyana, Gabon, Gambia (the), Ghana, Guinea, Guinea-Bissau, Guyana, Kenya, Liberia, Mali, Niger (the), Nigeria, Paraguay, Peru, Senegal, Sierra Leone, Suriname, Togo, Trinidad and Tobago, Venezuela (Bolivarian Republic of) Sao Tome Y Principe and Seychelles introduced but are not listed as at risk countries. Introduced in High risk areas Argentina, Brazil, Panama At risk but not introduced Burundi, Equatorial Guinea, Ethiopia, Mauritania, Rwanda, Somalia, South Sudan, Sudan (the), Uganda Introduced to date (32 countries or 73%) Introduced in High risk areas (3 countries or 7%) At risk but not introduced (9 countries or 20%) * WHO considers that 44 countries/Territories are at risk for Yellow fever Not Available / Not at risk Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Data source: WHO/IVB Database, as of 12 April 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

12 Countries and Territories using JE vaccine to date
At risk countries/areas but not introduced Bangladesh, Bhutan, Brunei Darussalam, Democratic People’s Republic of Korea (the), Indonesia, Myanmar, Pakistan, Philippines (the), Russian Federation and Singapore Introduced to date China, Japan, Republic of Korea, Sri Lanka, Thailand Introduced in the high risk areas: Australia Introduced in parts of the country Cambodia, India, Lao People's Democratic Republic, Malaysia, Nepal, Viet Nam At risk countries/areas but not introduced (11 countries or 50%) Introduced to date (6 countries or 27%) Introduced in parts of the country (5 countries or 23%) Not applicable Data source: WHO/IVB Database, as of 12 April 2016 International travel Health Database ( Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.


Download ppt "Vaccine in National Immunization Programme Update"

Similar presentations


Ads by Google